[18] |
黄远程,黄超原,梁怀枫,等.慢性非萎缩性胃炎与慢性萎缩性胃炎证候、证素分布规律文献研究[J].中医杂志,2019,60(16):1417-1422.
|
[19] |
陈润花,张厂,苏泽琦,等.非萎缩性胃炎到萎缩性胃炎的中医证候演变研究[J].北京中医药大学学报,2015,38(5):310-314.
|
[20] |
井晓磊,张勇勤,顾亚娇,等.吴茱萸槟榔汤加减穴位贴敷治疗慢性非萎缩性胃炎的临床观察[J].中国实验方剂学杂志,2019,25(12):104-109.
|
[21] |
李婷,张宇,张兆鹏,等.胁腹宁颗粒对慢性非萎缩性胃炎大鼠NF-κB 信号转导通路的影响[J].中国老年学杂志,2019,39(11):2739-2741.
|
[22] |
罗光芝,韩成恩,韩晓春,等.基于和法探讨黄连汤治疗慢性非萎缩性胃炎的机制[J].中国实验方剂学杂志,2019,25(18):36-42.
|
[23] |
郭虹忆,龙润,杨静,等.柴芩益胃汤治疗肝胃不和型慢性浅表性胃炎临床疗效及机制探讨[J].中国实验方剂学杂志,2018,24(5):166-170.
|
[2] |
中华医学会消化病学分会.中国慢性胃炎共识意见(2017年,上海)[J].中华消化杂志,2017,37(11):721-738.
|
[3] |
Du Y,Bai Y,Xie P,et al.Chronic gastritis in China:a national multi-center survey[J].BMC Gastroenterol,2014,14:21.
|
[1] |
Bai Y,Zou DW,Wu RP,et al.Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy:an endoscopic database review of 102,665 patients from 1996 to 2006[J].Gut,2010,59(6):722-728.
|
[4] |
Correa P,Haenszel W,Cuello C,et al.A model for gastric cancer epidemiology[J].Lancet,1975,2(7924):58-60.
|
[5] |
Correa P.A human model of gastric carcinogenesis[J].Cancer Res,1988,48(13):3554-3560.
|
[6] |
Correa P.Human gastric carcinogenesis:a multistep and multifactorial process-First American Cancer Society Award lecture on cancer epidemiology and prevention[J].Cancer Res,1992,52(24):6735-6740.
|
[7] |
Sipponen P,Maaroos HI.Chronic gastritis[J].Scand J Gastroenterol,2015,50(6):657-667.
|
[8] |
中华中医药学会脾胃病分会.慢性胃炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):3060-3064.
|
[9] |
中华中医药学会脾胃病分会.消化系统常见病慢性非萎缩性胃炎中医诊疗指南(基层医生版)[J].中华中医药杂志,2019,34(8):3613-3618.
|
[10] |
柯晓,王清泉.慢性浅表性胃炎中医药疗效评价述评[J].中医杂志,2015,56(22):1927-1930.
|
[11] |
Correa P,Piazuelo MB.The gastric precancerous cascade[J].J Digest Dis,2012,13(1):2-9.
|
[12] |
Diaz P,Valenzuela Valderrama M,Bravo J,et al.Helicobacter pylori and Gastric Cancer:Adaptive Cellular Mechanisms Involved in Disease Progression[J].Front Microbiol,2018,9:5.
|
[13] |
Kutluana U,Kolciler AG,Mizrak S,et al.Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?[J].Gastroenterol hepatol,2019,42(5):289-295.
|
[14] |
祁旦巳,张旭彤,高宝辉,等.幽门螺杆菌感染与慢性胃炎患者胃黏膜病理变化的相关性分析[J].中华医院感染学杂志,2016,26(16):3640-3642.
|
[15] |
李焕杰,高峰玉.雷贝拉唑钠肠溶片治疗老年浅表性胃炎的临床研究[J].中国临床药理学杂志,2017,33(11):986-988.
|
[16] |
余莹,王佳佳,徐银姝.3种艾司奥美拉唑给药方案对幽门螺杆菌阳性浅表性胃炎患者疗效及安全性的影响[J].中国中西医结合消化杂志,2019,27(6):447-451.
|
[17] |
石春勤,黄家俏,李秀华.替普瑞酮联合奥美拉唑对慢性浅表性胃炎患者T淋巴细胞及不良反应的影响[J].中国实用医药,2019,14(17):106-108.
|
[24] |
Alarcón T,Llorca L,Perez-Perez G.Impact of the Microbiota and Gastric Disease Development by Helicobacter pylori[J].Curr Top Microbiol Immunol,2017,400:253-275.
|
[25] |
张铁铭.半夏泻心汤加减治疗脾胃湿热型慢性浅表性胃炎的疗效观察[J].时珍国医国药,2018,29(2):384-385.
|
[26] |
朱耀宇,李红丽.加味半夏泻心汤对调养幽门螺旋杆菌相关性胃炎的临床分析[J].中华中医药学刊,2018,36(7):1764-1766.
|
[27] |
杜战国.舒胃愈胆胶囊联合奥美拉唑治疗慢性浅表性胃炎肝胃不和证的疗效观察[J].中国现代应用药学,2018,35(3):419-421.
|
[28] |
楼晓军,沈灵娜,陈洁,等.小柴胡汤联合替普瑞酮对慢性浅表性胃炎T淋巴细胞亚群及胃黏膜COX-2表达的影响[J].中药材,2016,39(12):2891-2893.
|
[29] |
邱新萍,王洪,邹济源,等.清利化浊方联合铋剂四联治疗幽门螺杆菌相关慢性非萎缩性胃炎脾胃湿热证40例临床观察[J].中医杂志,2016,57(5):405-408.
|
[30] |
庞士合.中西医结合治疗幽门螺杆菌阳性慢性浅表性胃炎的临床效果[J].河南医学研究,2018,27(22):4138-4139.
|
[31] |
刘乃勤.中西医结合治疗慢性浅表性胃炎脾胃湿热型疗效观察[J].实用中医药杂志,2018,34(12):1464-1465.
|
[32] |
王洪贵,唐仕伟,郑咏池.胃康胶囊联合常规西医治疗对慢性浅表性胃炎胃络瘀阻证的临床研究[J].现代消化及介入诊疗,2019,24(5):541-543.
|